News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
108,413 Results
Type
Article (4268)
Company Profile (18)
Press Release (104127)
Section
Business (32169)
Career Advice (108)
Deals (5290)
Drug Delivery (5)
Drug Development (5514)
Employer Resources (11)
FDA (3222)
Job Trends (2084)
News (47318)
Policy (3900)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
Academia (364)
Allergies (9)
Alliances (11195)
ALS (6)
Alzheimer's disease (308)
Antibody-drug conjugate (ADC) (3)
Approvals (3232)
Artificial intelligence (84)
Automation (3)
Bankruptcy (46)
Best Places to Work (1726)
Biosimilars (7)
Biotechnology (10)
Bladder cancer (9)
Brain cancer (5)
Breast cancer (57)
Cancer (390)
Cardiovascular disease (24)
Career advice (99)
Career pathing (1)
CAR-T (9)
Cell therapy (22)
Cervical cancer (7)
Clinical research (4275)
Collaboration (166)
Compensation (16)
COVID-19 (479)
C-suite (34)
Cystic fibrosis (8)
Data (236)
Decentralized trials (1)
Depression (4)
Diabetes (16)
Diagnostics (5792)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (13)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (5)
Earnings (10506)
Employer branding (2)
Employer resources (11)
Events (13623)
Executive appointments (103)
FDA (3396)
Featured Employer (2)
Fibrodysplasia Ossificans Progressiva (1)
Funding (122)
Gene editing (1)
Generative AI (8)
Gene therapy (13)
GLP-1 (41)
Government (626)
Guidances (5)
Healthcare (2930)
IgA nephropathy (1)
Immunology and inflammation (6)
Indications (3)
Infectious disease (505)
Inflammatory bowel disease (12)
Influenza (10)
Intellectual property (6)
Interviews (12)
IPO (1817)
IRA (1)
Job creations (401)
Job search strategy (94)
Kidney cancer (4)
Labor market (1)
Layoffs (24)
Leadership (1)
Legal (539)
Liver cancer (11)
Lung cancer (45)
Lymphoma (28)
Machine learning (1)
Management (3)
Manufacturing (42)
MASH (4)
Medical device (2463)
Medtech (2463)
Mergers & acquisitions (3554)
Metabolic disorders (33)
Multiple sclerosis (18)
NASH (3)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (361)
NextGen: Class of 2025 (733)
Non-profit (547)
Northern California (330)
Now hiring (2)
Obesity (13)
Opinion (11)
Ovarian cancer (13)
Pain (3)
Pancreatic cancer (10)
Parkinson's disease (14)
Partnered (3)
Patents (19)
Patient recruitment (9)
Peanut (4)
People (9024)
Pharmaceutical (1)
Phase I (1288)
Phase II (1804)
Phase III (1634)
Pipeline (117)
Podcasts (1)
Policy (1)
Postmarket research (214)
Preclinical (598)
Press Release (11)
Prostate cancer (33)
Psychedelics (1)
Radiopharmaceuticals (120)
Rare diseases (30)
Real estate (863)
Recruiting (5)
Regulatory (3026)
Reports (10)
Research institute (430)
Resumes & cover letters (15)
Rett syndrome (1)
Schizophrenia (1)
Series A (16)
Series B (12)
Service/supplier (2)
Sickle cell disease (3)
Southern California (266)
Spinal muscular atrophy (10)
Sponsored (5)
Startups (625)
Stomach cancer (2)
Supply chain (4)
The Weekly (1)
United States (2928)
Vaccines (39)
Venture capitalists (6)
Weight loss (4)
Women's health (6)
Date
Today (26)
Last 7 days (109)
Last 30 days (361)
Last 365 days (5050)
2025 (1322)
2024 (5156)
2023 (6204)
2022 (10266)
2021 (9672)
2020 (9012)
2019 (6217)
2018 (4882)
2017 (5415)
2016 (5418)
2015 (6154)
2014 (4643)
2013 (4133)
2012 (4448)
2011 (4642)
2010 (4094)
Location
Africa (131)
Alabama (6)
Alaska (1)
Arizona (54)
Arkansas (2)
Asia (5362)
Australia (1246)
California (715)
Canada (251)
China (30)
Colorado (49)
Connecticut (60)
Delaware (6)
Europe (15361)
Florida (95)
Georgia (37)
Idaho (4)
Illinois (93)
India (4)
Indiana (31)
Iowa (3)
Japan (21)
Kansas (11)
Kentucky (4)
Louisiana (1)
Maine (20)
Maryland (94)
Massachusetts (388)
Michigan (64)
Minnesota (71)
Missouri (28)
Montana (4)
Nebraska (8)
Nevada (1)
New Hampshire (18)
New Jersey (138)
New Mexico (17)
New York (280)
North Carolina (179)
North Dakota (6)
Northern California (330)
Ohio (28)
Oklahoma (2)
Oregon (7)
Pennsylvania (78)
Rhode Island (4)
South America (154)
South Carolina (3)
Southern California (266)
Tennessee (26)
Texas (163)
Utah (76)
Virginia (35)
Washington D.C. (6)
Washington State (65)
Wisconsin (29)
108,413 Results for "vela diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan
Vela Diagnostics announced a research collaboration with SRL Inc, a premier Japanese healthcare service company.
October 2, 2023
·
2 min read
Press Releases
Early Detection Of Breast Cancer Seen As A Benefit With Seated Option in the VELA Mammography Chair, Enable Me Finds in Technologist Survey
February 12, 2025
·
3 min read
MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa
MoonLake Immunotherapeutics today announced that the first patients have been screened at a U.S. trial site in its global Phase 3 clinical program, VELA, evaluating sonelokimab, an investigational Nanobody® designed to treat inflammatory disease, in patients with moderate-to-severe hidradenitis suppurativa (HS).
May 16, 2024
·
13 min read
Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus
Vela Diagnostics announced that it has developed a PCR test kit to detect the monkeypox virus, for research use only.
July 26, 2022
·
2 min read
Drug Development
Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya
Vela Diagnostics has announced its appointment by the National Public Health Laboratory of Kenya as their supplier for SARS-CoV-2 genotyping tests, with funding from The Global Fund.
August 3, 2022
·
3 min read
Pharm Country
Vela Diagnostics Launches Multiplex PCR-Based Test for Detecting UTI Pathogens and Antimicrobial Resistance Genes
Vela Diagnostics announced today the launch of its new PathoKey® MP UTI ID and AMR PCR Test for research use only (RUO*).
May 17, 2022
·
3 min read
Partnered
Ending the Diagnostic Odyssey for Patients
Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.
December 11, 2024
·
4 min read
·
BioSpace Insights
Drug Development
Blueprint Medicines Announces Lift of Partial Clinical Hold on Phase 1/2 VELA Trial of BLU-222
Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the U.S. Food and Drug Administration (FDA) has lifted a partial clinical hold on the Phase 1/2 VELA trial of BLU-222.
March 28, 2023
·
5 min read
Press Releases
Newly-formed Archerfish Precision Diagnostics Pte Ltd: Ushers a New Era in Advanced Diagnostics
March 6, 2025
·
5 min read
Pharm Country
Media Pooling Strategy to Increase Testing Throughput Added to Vela Diagnostics’ ViroKey SARS-CoV-2 RT-PCR Test v2.0
Vela Diagnostics has announced that its ViroKey® SARS-CoV-2 RT-PCR Test v2.0 now has the additional capability to be used for pooling, using a three-in-one media pooling strategy.
April 22, 2022
·
2 min read
1 of 10,842
Next
